Milestone Pharmaceuticals, Inc.

( )
MIST PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 1.60%142.000.7%$2300.21m
PFEPfizer Inc. 1.51%35.050.9%$1484.99m
MRKMerck & Co., Inc. 0.83%81.010.7%$1358.28m
ABBVAbbVie, Inc. 2.57%77.502.3%$1259.47m
BMYBristol-Myers Squibb Co. 1.91%58.841.0%$1179.06m
LLYEli Lilly & Co. 2.07%144.231.1%$890.88m
NVSNovartis AG 0.63%86.340.2%$307.67m
AZNAstraZeneca Plc -1.56%43.611.2%$296.87m
GSKGlaxoSmithKline Plc 0.34%38.050.2%$259.20m
SNYSanofi -1.39%45.480.2%$174.48m
NVONovo Nordisk A/S -1.09%60.020.1%$169.91m
FTSVForty Seven, Inc. 0.05%95.510.0%$152.45m
BHCBausch Health Cos., Inc. 4.38%15.250.0%$101.84m
RGENRepligen Corp. 2.55%100.717.1%$73.73m
RETAReata Pharmaceuticals, Inc. 0.00%138.293.4%$66.79m

Company Profile

Milestone Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercialization of novel small molecule therapeutics based on clinically-validated mechanisms for the treatment of cardiovascular diseases. The firm designs and develops a rapid-onset nasal spray with Etripamil. The company was founded by Philippe Douville and Philippe Lamarre in 2005 and is headquartered in Montreal, Canada.